Deciphering complexity of GPCR signaling and modulation: implications and perspectives for drug discovery

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• G protein-coupled receptors (GPCRs) are key drug targets, with recent advances like biased agonism expanding therapeutic potential.
• Tachyphylaxis, or rapid receptor desensitization, poses a challenge for chronic GPCR-targeted therapies.
• Understanding GPCR modulation is crucial for developing effective treatments with minimized side effects.

Purpose of the Study:

• To investigate the primary mechanism driving tachyphylaxis in angiotensin type 1 (AT1) receptors.
• To explore the role of ligand residence time and sustained intracellular signaling in GPCR responsiveness.
• To highlight novel therapeutic strategies for GPCRs, including targeting intracellular signaling and developing cell-permeant antagonists.

Main Methods:

• Analysis of tachyphylaxis in AT1 receptors, focusing on ligand dissociation rates (koff) and residence time.
• Investigation of sustained signaling from internalized receptors within endosomes.
• Review of advanced techniques like high-resolution imaging and biosensors for studying GPCR dynamics.

Main Results:

• Tachyphylaxis in AT1 receptors is primarily governed by ligand dissociation rate (high residence time), not β-arrestin-mediated desensitization.
• Internalized AT1 receptors remain active when bound by high residence time ligands, enabling sustained endosomal signaling.
• High residence time offers a new perspective on intracellular GPCR signaling and therapeutic modulation.

Conclusions:

• Ligand residence time is a critical parameter for GPCR drug discovery, influencing tachyphylaxis and sustained signaling.
• Targeting intracellular GPCR activity and developing cell-permeant antagonists represent promising therapeutic avenues.
• Advanced imaging and computational methods are essential for understanding complex GPCR behaviors and designing next-generation therapies.